LUCIUS 卢修斯 司美替尼 Selumetinib纤维瘤

司美替尼

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Selumetinib

老挝国家食药监局批准上市
老挝国家药检所检测认证

纤维瘤

Each capsule contains Selumetinib sulfate
12. Img eouivalent to Selumetinib ........ 10mg

LUCiUS

Indication:

PHARMACEUTICALS

clcne is a knase innioitor indicated for the
treatment of pediatric patients 2 vears of aee3
older with neurofiromatotis
c, mnoperable plexiform

The recommended dosage is 25 mg/m taken

LuciSelume

arllutuiea daslu ne an emnty stomach. Do not
colsume tood 2 hours before each dose or I hour
*Reduce the recommended dosaee to 20 mg m

Selumetinib

FDA批准

orally twice daily for patients with moderate

Capsules

Impatrment (Child-Puel B) The

ts with moderate
recommended dosage for use in patients with
parment |Child-Pugh C]has

10mg

not been establishe

Storasoeins

ge: in a dry place and store at 20°C to 25°C.
Keep medicine out of reach of Children. Do not
dministered LueiSelume in Pregnancy and
Lactation paticnt treatment.
PLEASE SEEPACKAGE INSERT

60 Capsules

Manufactured and Marketed by
LUCIUS

权威认证

Thongmang village. Xaythany district
Vientiane Capital, Laos
Warning: To be sold by retail on prescription
of reoistered nlucicitns on
byehcias only, and as dirested

Rx only

口碑质量

适应症:
适用于2岁及以上患有1型神经纤维瘤病(NF1)的儿童患者,这些
患者患有症状性、无法手术的丛状神经纤维瘤 PN)。
推荐剂量:
1、25mg/m2,每天2次(约每12小时一次),口服给药,直至疾病进
展或出现不可接受的毒性;
2、空腹服用(饭前1小时或饭后2小时);
3、整粒吞服,不要咀嚼,溶解或打开胶囊。